This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Biocon Limited. Active years: 2019-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2021
Title: Innovations by Shanmughasamy Rajmahendra
Introduction
Shanmughasamy Rajmahendra is a notable inventor based in Chennai, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel crystalline forms of various compounds. With a total of 3 patents to his name, his work has the potential to impact the industry positively.
Latest Patents
Rajmahendra's latest patents include the invention of crystalline linagliptin intermediate and a process for the preparation of linagliptin. This invention provides novel crystalline forms B1 and B2 of the linagliptin intermediate, along with methods for their production. Another significant patent involves crystalline forms of posaconazole intermediate and a process for the preparation of amorphous posaconazole. This invention outlines an industrial method for producing amorphous posaconazole and relates to novel crystalline forms of posaconazole intermediate, which is a key intermediate in the production of posaconazole.
Career Highlights
Shanmughasamy Rajmahendra is currently employed at Biocon Limited, a leading biopharmaceutical company. His work at Biocon has allowed him to focus on innovative solutions in drug development and production.
Collaborations
He has collaborated with notable coworkers, including Palle Venkata Raghavendra Charyulu and Dharshan Jakkali Chandre Gowda, contributing to a dynamic and innovative work environment.
Conclusion
Shanmughasamy Rajmahendra's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in drug development and production.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
